Summary: Artrya gets more marketing approvals for AI software after US FDA setback and more holds

Artrya secures UK, EU approval for Salix

Within a week, ASX-listed pharmatech company Artrya received both European Union and UK regulatory approval for its Salix Coronary Anatomy product.

The AI-powered software detects and diagnoses arterial plaque to diagnose coronary artery disease.

The recent approvals allow Artrya to market Salix in 28 EU member states and in the UK, where it already has a four-year contract to supply 1,250 National Health Service Trust hospitals with the product.

The approvals also represent a victory for the company after suffering a major setback in June when the US Food and Drug Administration rejected the initial 510(k) application for its software product.

Meanwhile, Salix is ​​now ready for commercialization in Australia and New Zealand after securing authorizations over the past two years.

Global Health to deliver patient engagement, data solutions for upcoming George Center

Registered health technology company Global Health has signed an agreement to deploy its patient engagement and data solutions to the soon-to-be-built The George Center by Acurio Health Group.

Global Health will deliver the MasterCare PAS, patient portal, data warehouse and electronic switch integration engine to The George Centre, with construction scheduled to be completed later this year. The Health and Wellness Center is envisioned to be one of the largest private maternity and children’s hospitals in New South Wales.

Orion Health hires new clinical director

Orion Health has appointed a former Southern Cross Healthcare director as its new clinical director for New Zealand and Australia.

Carey Campbell was the Director of Nursing at Southern Cross Healthcare, a position she held since 2008. She was the clinical lead and product owner for the partnership between Orion Health and Southern Cross Healthcare, which oversaw the implementation of EMRs at 16 Southern Cross hospitals in the country. land.

She also previously held a number of leadership roles at the former Waikato District Health Board.

In his new role, Campbell will engage and work with customers and local communities as their advocate.

“We know that the expertise Carey brings from her time at Southern Cross Healthcare and Waikato DHB puts her in an excellent position to hit the ground running at Orion Health,” Orion Health CEO Brad Porter said of Campbell’s appointment.

RMIT researchers are working on a mobile thermal imaging device to screen chronic wounds

A research team from RMIT University and the Bolton Clarke Research Institute is working to get their thermal imaging device to screen chronic wounds on mobile phones.

This comes after they were able to demonstrate much faster diagnosis of chronic leg ulcers using AI technology in a recent clinical trial. study.

“Our new work identifying chronic leg ulcers at the first visit is a world first,” said lead researcher Dinesh Kumar, who is also a professor at the RMIT School of Engineering.

While thermal imaging has been used frequently to detect chronic wounds, the team’s AI system can make a “significantly earlier” diagnosis than current methods.

“Our innovation is not sensitive to changes in ambient temperature and light, so it is effective for nurses to use it during regular visits to people’s homes,” explained co-researcher Dr Quoc Cuong Ngo.

The research team is now continuing to work on a mobile version of their thermal imaging solution after receiving a grant from the federal Futures Fund for Medical Research.

They are also looking to evaluate whether their AI technology can also predict the healing of diabetic foot ulcers.

Leave a Comment

Your email address will not be published. Required fields are marked *